Journal
FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.698236
Keywords
m(6)A (N6-methyladenosine); lung adenocarcinoma; tumor microenvironment; immune infiltration; immunotherapy
Categories
Funding
- Institutional Fundamental Research Funds [2018PT32033]
- Ministry of Education Innovation Team Development Project [IRT-17R10]
- ETHICON.Excellent in surgery grant [2018-011-ZZ]
Ask authors/readers for more resources
Recent studies have shown that m(6)A modification is closely associated with immune infiltration in early-stage lung adenocarcinoma (LUAD). By establishing m(6)A-predictive score, immunotherapeutic responses of patients can be predicted. Patients in different m(6)A gene-related clusters exhibit significant differences in immune characteristics and overall survival rates.
Recent publications have revealed that N6-methyladenosine (m(6)A) modification is critically involved in tumorigenesis and metastasis. However, the correlation of m(6)A modification and immune infiltration in early-stage lung adenocarcinoma (LUAD) is still uncertain. We performed NMF clustering based on 23 m(6)A regulators and identify three distinct m(6)A clusters and three m(6)A related genes clusters (m(6)A cluster-R) in early-stage LUAD. The immune infiltrating levels were calculated using CIBERSORT, MCPcounter and ssGSEA algorithms. And we established the m(6)A-predictive score to quantify m(6)A modified phenotypes and predict immunotherapeutic responses. Based on the TME characteristics, different immune profiles were also identified among three m(6)A gene-related clusters. And the m(6)A-R-C2 was related to a favorable overall survival (OS), whereas m(6)A-R-C3 had unfavorable overall survival. The m(6)A-predictive score was built according to the expression levels of m(6)A-related genes, and patients could be stratified into subgroups with low/high scores. Patients with high scores had poor overall survival, enhanced immune infiltration, high tumor mutation burden and increased level of somatic mutation. Besides, patients with high scores had unfavorable overall survival in the anti-PD-1 cohort, whereas the overall survival of high-score patients was better in the adoptive T cell therapy cohort. Our work highlights that m(6)A modification is closely related to immune infiltration in early-stage LUAD, which also contributes to the development of more effective immunotherapy strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available